Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Hodgkin Lymphoma Treatment Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Hodgkin Lymphoma Treatment Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Alocrest
      • 1.3.3 ANK Program
      • 1.3.4 Azacitidine
      • 1.3.5 BMS-986016
      • 1.3.6 BPX-501
      • 1.3.7 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Hodgkin Lymphoma Treatment Market Share by Application (2019-2025)
      • 1.4.2 Hospital
      • 1.4.3 Clinic
      • 1.4.4 Research Center
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Hodgkin Lymphoma Treatment Market Size
      • 2.1.1 Global Hodgkin Lymphoma Treatment Revenue 2014-2025
      • 2.1.2 Global Hodgkin Lymphoma Treatment Sales 2014-2025
    • 2.2 Hodgkin Lymphoma Treatment Growth Rate by Regions
      • 2.2.1 Global Hodgkin Lymphoma Treatment Sales by Regions 2014-2019
      • 2.2.2 Global Hodgkin Lymphoma Treatment Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Hodgkin Lymphoma Treatment Sales by Manufacturers
      • 3.1.1 Hodgkin Lymphoma Treatment Sales by Manufacturers 2014-2019
      • 3.1.2 Hodgkin Lymphoma Treatment Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Hodgkin Lymphoma Treatment Revenue by Manufacturers (2014-2019)
      • 3.2.2 Hodgkin Lymphoma Treatment Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Hodgkin Lymphoma Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.3 Hodgkin Lymphoma Treatment Price by Manufacturers
    • 3.4 Key Manufacturers Hodgkin Lymphoma Treatment Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Hodgkin Lymphoma Treatment Market
    • 3.6 Key Manufacturers Hodgkin Lymphoma Treatment Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Alocrest Sales and Revenue (2014-2019)
      • 4.1.2 ANK Program Sales and Revenue (2014-2019)
      • 4.1.3 Azacitidine Sales and Revenue (2014-2019)
      • 4.1.4 BMS-986016 Sales and Revenue (2014-2019)
      • 4.1.5 BPX-501 Sales and Revenue (2014-2019)
      • 4.1.6 Others Sales and Revenue (2014-2019)
    • 4.2 Global Hodgkin Lymphoma Treatment Sales Market Share by Type
    • 4.3 Global Hodgkin Lymphoma Treatment Revenue Market Share by Type
    • 4.4 Hodgkin Lymphoma Treatment Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Hodgkin Lymphoma Treatment Sales by Application

    6 United States

    • 6.1 United States Hodgkin Lymphoma Treatment Breakdown Data by Company
    • 6.2 United States Hodgkin Lymphoma Treatment Breakdown Data by Type
    • 6.3 United States Hodgkin Lymphoma Treatment Breakdown Data by Application

    7 European Union

    • 7.1 European Union Hodgkin Lymphoma Treatment Breakdown Data by Company
    • 7.2 European Union Hodgkin Lymphoma Treatment Breakdown Data by Type
    • 7.3 European Union Hodgkin Lymphoma Treatment Breakdown Data by Application

    8 China

    • 8.1 China Hodgkin Lymphoma Treatment Breakdown Data by Company
    • 8.2 China Hodgkin Lymphoma Treatment Breakdown Data by Type
    • 8.3 China Hodgkin Lymphoma Treatment Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Hodgkin Lymphoma Treatment Breakdown Data by Company
    • 9.2 Rest of World Hodgkin Lymphoma Treatment Breakdown Data by Type
    • 9.3 Rest of World Hodgkin Lymphoma Treatment Breakdown Data by Application
    • 9.4 Rest of World Hodgkin Lymphoma Treatment Breakdown Data by Countries
      • 9.4.1 Rest of World Hodgkin Lymphoma Treatment Sales by Countries
      • 9.4.2 Rest of World Hodgkin Lymphoma Treatment Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Cell Medica Limited
      • 10.1.1 Cell Medica Limited Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Hodgkin Lymphoma Treatment
      • 10.1.4 Hodgkin Lymphoma Treatment Product Introduction
      • 10.1.5 Cell Medica Limited Recent Development
    • 10.2 Cellular Biomedicine Group, Inc.
      • 10.2.1 Cellular Biomedicine Group, Inc. Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Hodgkin Lymphoma Treatment
      • 10.2.4 Hodgkin Lymphoma Treatment Product Introduction
      • 10.2.5 Cellular Biomedicine Group, Inc. Recent Development
    • 10.3 Constellation Pharmaceuticals, Inc.
      • 10.3.1 Constellation Pharmaceuticals, Inc. Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Hodgkin Lymphoma Treatment
      • 10.3.4 Hodgkin Lymphoma Treatment Product Introduction
      • 10.3.5 Constellation Pharmaceuticals, Inc. Recent Development
    • 10.4 Curis, Inc.
      • 10.4.1 Curis, Inc. Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Hodgkin Lymphoma Treatment
      • 10.4.4 Hodgkin Lymphoma Treatment Product Introduction
      • 10.4.5 Curis, Inc. Recent Development
    • 10.5 Faron Pharmaceuticals Oy
      • 10.5.1 Faron Pharmaceuticals Oy Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Hodgkin Lymphoma Treatment
      • 10.5.4 Hodgkin Lymphoma Treatment Product Introduction
      • 10.5.5 Faron Pharmaceuticals Oy Recent Development
    • 10.6 Fate Therapeutics, Inc.
      • 10.6.1 Fate Therapeutics, Inc. Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Hodgkin Lymphoma Treatment
      • 10.6.4 Hodgkin Lymphoma Treatment Product Introduction
      • 10.6.5 Fate Therapeutics, Inc. Recent Development
    • 10.7 Gamida Cell Ltd.
      • 10.7.1 Gamida Cell Ltd. Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Hodgkin Lymphoma Treatment
      • 10.7.4 Hodgkin Lymphoma Treatment Product Introduction
      • 10.7.5 Gamida Cell Ltd. Recent Development
    • 10.8 Gilead Sciences, Inc.
      • 10.8.1 Gilead Sciences, Inc. Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Hodgkin Lymphoma Treatment
      • 10.8.4 Hodgkin Lymphoma Treatment Product Introduction
      • 10.8.5 Gilead Sciences, Inc. Recent Development
    • 10.9 Incyte Corporation
      • 10.9.1 Incyte Corporation Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Hodgkin Lymphoma Treatment
      • 10.9.4 Hodgkin Lymphoma Treatment Product Introduction
      • 10.9.5 Incyte Corporation Recent Development
    • 10.10 Merck & Co., Inc.
      • 10.10.1 Merck & Co., Inc. Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Hodgkin Lymphoma Treatment
      • 10.10.4 Hodgkin Lymphoma Treatment Product Introduction
      • 10.10.5 Merck & Co., Inc. Recent Development
    • 10.11 Mirati Therapeutics Inc.
    • 10.12 Molecular Templates Inc.
    • 10.13 NantKwest, Inc.

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Hodgkin Lymphoma Treatment Sales Channels
      • 11.2.2 Hodgkin Lymphoma Treatment Distributors
    • 11.3 Hodgkin Lymphoma Treatment Customers

    12 Market Forecast

    • 12.1 Global Hodgkin Lymphoma Treatment Sales and Revenue Forecast 2019-2025
    • 12.2 Global Hodgkin Lymphoma Treatment Sales Forecast by Type
    • 12.3 Global Hodgkin Lymphoma Treatment Sales Forecast by Application
    • 12.4 Hodgkin Lymphoma Treatment Forecast by Regions
      • 12.4.1 Global Hodgkin Lymphoma Treatment Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Hodgkin Lymphoma Treatment Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Hodgkin Lymphoma Treatment is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Hodgkin Lymphoma Treatment.

      This report studies the global market size of Hodgkin Lymphoma Treatment, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Hodgkin Lymphoma Treatment sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Cell Medica Limited
      Cellular Biomedicine Group, Inc.
      Constellation Pharmaceuticals, Inc.
      Curis, Inc.
      Faron Pharmaceuticals Oy
      Fate Therapeutics, Inc.
      Gamida Cell Ltd.
      Gilead Sciences, Inc.
      Incyte Corporation
      Merck & Co., Inc.
      Mirati Therapeutics Inc.
      Molecular Templates Inc.
      NantKwest, Inc.

      Market Segment by Product Type
      Alocrest
      ANK Program
      Azacitidine
      BMS-986016
      BPX-501
      Others

      Market Segment by Application
      Hospital
      Clinic
      Research Center

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Hodgkin Lymphoma Treatment status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Hodgkin Lymphoma Treatment manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Hodgkin Lymphoma Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now